Preventing intrahepatic infection after ablation of liver tumours in biliary-enteric anastomosis patients

References

• Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. (1997). Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195–200.
   PubMed Web of Science ®Google Scholar
• Sperti C, Moletta L, Merigliano S. (2015). Multimodality treatment of recurrent pancreatic cancer: myth or reality? World J Gastrointest Oncol 7:375–82.
   PubMed Web of Science ®Google Scholar
• Takada T, Amano H, Yasuda H, et al. (2002). Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685–95.
   PubMed Web of Science ®Google Scholar
• Sikora SS, Balachandran P, Dimri K, et al. (2005). Adjuvant chemo-radiotherapy in ampullary cancers. Eur J Surg Oncol 31:158–63.
   PubMed Web of Science ®Google Scholar
• Liang P, Yu J, Lu MD, et al. (2013). Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy. World J Gastroenterol 19:5430–8.
   PubMed Web of Science ®Google Scholar
• Robert CG, Martin MD, Charles R, et al. (2010). Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 17:171–8.
   PubMed Web of Science ®Google Scholar
• Ikai I, Itai Y, Okita K, et al. (2004). Report of the 15th follow-up survey of primary liver cancer. Hepatol Res 28:21–9.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P. (2016). Status and advancement of microwave ablation in China. Int J Hyperthermia 20:1–10.
   Web of Science ®Google Scholar
• Ong SL, Gravante G, Metcalfe MS, et al. (2009). Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. Eur J Gastroenterol Hepatol 21:599–605.
   PubMed Web of Science ®Google Scholar
• Lloyd DM, Lau KN, Welsh F, et al. (2011). International multicentre prospective study on microwave ablation of liver tumours: preliminary results. HPB (Oxford) 13:579–85.
   PubMed Web of Science ®Google Scholar
• Bhardwaj N, Strickland AD, Ahmad F, et al. (2010). Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol 36:264–8.
   PubMed Web of Science ®Google Scholar
• Jiao D, Qian L, Zhang Y, et al. (2010). Microwave ablation treatment of liver cancer with 2,450-MHz cooled-shaft antenna: an experimental and clinical study. J Cancer Res Clin Oncol 136:1507–16.
   PubMed Web of Science ®Google Scholar
• Boutros C, Somasundar P, Garrean S, et al. (2010). Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol 19:e22–32.
   PubMed Web of Science ®Google Scholar
• Inokuchi R, Seki T, Ikeda K, et al. (2010). Percutaneous microwave coagulation therapy for hepatocellular carcinoma: increased coagulation diameter using a new electrode and microwave generator. Oncol Rep 24:621–7.
   PubMed Web of Science ®Google Scholar
• Meloni MF, Chiang J, Laeseke PF, et al. (2017). Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia 33:15–24.
   PubMed Web of Science ®Google Scholar
• Shibata T, Yamamoto Y, Yamamoto N, et al. (2003). Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol 14:1535–42.
   PubMed Web of Science ®Google Scholar
• Yu MA, Liang P, Yu XL, et al. (2011). Liver abscess as a complication of microwave ablation for liver metastatic cholangiocarcinoma after bilioenteric anastomosis. Int J Hyperthermia 27:503–9.
   PubMed Web of Science ®Google Scholar
• Chuang JH, Chen WJ, Lee SY, Chang NK. (1998). Prompt colonization of the hepaticojejunostomy and translocation of bacteria to liver after bile duct reconstruction. J Pediatr Surg 33:1215–8.
   PubMed Web of Science ®Google Scholar
• Elias D, Di Pietroantonio D, Gachot B, et al. (2006). Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure. Gastroenterol Clin Biol 30:823–7.
   PubMedGoogle Scholar
• de Baère T, Risse O, Kuoch V, et al. (2003). Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 181:695–700.
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu XL, Dong B. (2009). Malignant liver tumors: treatment with percutaneous microwave ablation — complications among cohort of 1136 patients. Radiology 251:933–40.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Solbiati L, Meloni MF, et al. (2003). Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–51.
   PubMed Web of Science ®Google Scholar
• Decadt B, Siriwardena AK. (2004). Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 5:550–60.
   PubMed Web of Science ®Google Scholar
• Laukkarinen J, Chow P, Sand J, et al. (2007). Long-term changes in hepatobiliary physiology after Roux-en-Y hepaticojejunostomy. J Surg Res 143:270–5.
   PubMed Web of Science ®Google Scholar
• Summers GE, Jr, Hocking MP. (1992). Preoperative and postoperative motility disorders of the stomach. Surg Clin North Am 72:467–86.
   PubMed Web of Science ®Google Scholar
• Johnson CP, Sarna SK, Cowles VE, et al. Motor activity and transit in the autonomically denervated jejunum. Am J Surg 1994; 167:80–8.
   PubMed Web of Science ®Google Scholar
• Choi D, Lim HK, Kim MJ, et al. (2005). Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol 184:1860–7.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Rempp H, Schmidt D, et al. (2012). Prolonged antibiotic prophylaxis in patients with bilioenteric anastomosis undergoing percutaneous radiofrequency ablation. J Vasc Interv Radiol 23:545–51.
   PubMed Web of Science ®Google Scholar
• Geschwind JF, Kaushik S, Ramsey DE, et al. (2002). Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13:1163–6.
   PubMed Web of Science ®Google Scholar